Search

Author/Creator Lopez-Botet, Miguel

1. Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells. (3rd July 2019)

Authors:
Ochoa, Maria C.; Perez-Ruiz, Elisabeth; Minute, Luna; Oñate, Carmen; Perez, Guiomar; Rodriguez, Inmaculada; Zabaleta, Aintzane; Alignani, Diego; Fernandez-Sendin, Myriam; Lopez, Ascension; Muntasell, Aura; Sanmamed, Miguel F.; Paiva, Bruno; Lopez-Botet, Miguel; Berraondo, Pedro; Melero, Ignacio
Journal:
Oncoimmunology
Issue:
Volume 8:Number 7(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer. (3rd June 2019)

Authors:
Hardy-Werbin, Max; Rocha, Pedro; Arpi, Oriol; Taus, Álvaro; Nonell, Lara; Durán, Xavier; Villanueva, Xavier; Joseph-Pietras, Deborah; Nolan, Luke; Danson, Sarah; Griffiths, Richard; Lopez-Botet, Miguel; Rovira, Ana; Albanell, Joan; Ottensmeier, Christian; Arriola, Edurne
Journal:
Oncoimmunology
Issue:
Volume 8:Number 6(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search